ConductScience.org, home
A Study of Olaratumab in Soft Tissue Sarcoma
API referenceFor AI assistants

Trial · NCT01185964

Participant flow28

How many started, completed or left each group, period by period.

1 to 20 of 28

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Phase 1b and Phase 2STARTEDPhase 1b: Olaratumab + Doxorubicin15
Phase 1b and Phase 2STARTEDPhase 2: Olaratumab + Doxorubicin66
Phase 1b and Phase 2STARTEDPhase 2: Doxorubicin67
Phase 1b and Phase 2STARTEDPhase 2: Doxorubicin: Optional Olaratumab After Progression0
Phase 1b and Phase 2Received at Least 1 Dose of Study DrugPhase 1b: Olaratumab + Doxorubicin15
Phase 1b and Phase 2Received at Least 1 Dose of Study DrugPhase 2: Olaratumab + Doxorubicin64
Phase 1b and Phase 2Received at Least 1 Dose of Study DrugPhase 2: Doxorubicin65
Phase 1b and Phase 2Received at Least 1 Dose of Study DrugPhase 2: Doxorubicin: Optional Olaratumab After Progression0
Phase 1b and Phase 2COMPLETEDPhase 1b: Olaratumab + Doxorubicin13
Phase 1b and Phase 2COMPLETEDPhase 2: Olaratumab + Doxorubicin56
Phase 1b and Phase 2COMPLETEDPhase 2: Doxorubicin58
Phase 1b and Phase 2COMPLETEDPhase 2: Doxorubicin: Optional Olaratumab After Progression0
Phase 1b and Phase 2NOT COMPLETEDPhase 1b: Olaratumab + Doxorubicin2
Phase 1b and Phase 2NOT COMPLETEDPhase 2: Olaratumab + Doxorubicin10
Phase 1b and Phase 2NOT COMPLETEDPhase 2: Doxorubicin9
Phase 1b and Phase 2NOT COMPLETEDPhase 2: Doxorubicin: Optional Olaratumab After Progression0
Optional Olaratumab Monotherapy on DoxSTARTEDPhase 1b: Olaratumab + Doxorubicin0
Optional Olaratumab Monotherapy on DoxSTARTEDPhase 2: Olaratumab + Doxorubicin0
Optional Olaratumab Monotherapy on DoxSTARTEDPhase 2: Doxorubicin0
Optional Olaratumab Monotherapy on DoxSTARTEDPhase 2: Doxorubicin: Optional Olaratumab After Progression30

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01185964/flow

API referenceFor AI assistants